Furthermore, SPEN mutation was significantly correlated with tumor-infiltrating lymphocytes, immunoinhibitors, immunostimulators, MHC, chemokines, and chemokine receptors, and SPEN expression was positively correlated with immune checkpoint genes. The gene discussed is SPEN; the disease is neoplasm.